...
首页> 外文期刊>Advances in Analytical Chemistry >Synthesis, Characterization and Antimicrobial Activity of V(IV), Ag(I) and Cd(II) Complexes with Mixed Ligands Derived from Sulfamethoxazole and Trimethoprim
【24h】

Synthesis, Characterization and Antimicrobial Activity of V(IV), Ag(I) and Cd(II) Complexes with Mixed Ligands Derived from Sulfamethoxazole and Trimethoprim

机译:具有磺胺甲恶唑和甲氧苄啶的混合配体的V(IV),Ag(I)和Cd(II)配合物的合成,表征和抗菌活性

获取原文

摘要

A series of new metal complexes were prepared by mixing 4-amino-N-(5-methylisoxazole-3-yl)-benzene -sulfonamide (L1) as a chelating ligand in the presence of the co-ligand trimethoprim (L2), with Vanadium (V), Cadmium (Cd) and Silver (Ag) ions in alcoholic medium. The complexes were characterized in solid state by using flame atomic absorption, elemental analysis C.H.N.S, FT-IR, UV-Vis Spectroscopy, conductivity and magnetic susceptibility measurements. Tetrahedral geometry was suggested for CdL1L2, AgL1L2 complexes, while VL1L2 complex has a square pyramidal. The ligand L1, with the metal ions, was clearly behaving as a bidentate through O and N atoms of sulfonylamid, while L2 behaves as a bidentate ligand through N and N atoms for all the complexes. Conductivity has shown that all the preparations complexes are ionized, and the nature of bonding between the metal ion and the donor atoms of the ligands was demonstrated by calculating the ligand field parameters by using suitable Tanaba-Sugano diagrams. Biological activity of V(IV), Cd(II), Ag(I), TMP, and SMX, with different concentrations (50, 100, 250, 500, and 1000)ppm, were studied respectively, complexes with chelating ligand and co-ligand were evaluated against Staphylococcus aureus , Pseudomonas aeruginosa and Escherichia coli , after incubating for 24hr at 37oC. Results showed that L1 and L2 enhance effect of (V) against growth of (Staph. aureus and E. coli ) with concentration (50, 100, 250, 500, and 1000)ppm, while Ps. aeruginosa was sensitized to (Cd) and (Ag) with concentration more than (250)ppm, after incubated for 24hr at 37oC. Whereas, the SMX is exposed to a failure in its efficiency against Staph. aureus , Ps. aeruginosa , and E. coli .
机译:在共配体甲氧苄啶(L2)存在下,将4-氨基-N-(5-甲基异恶唑-3-基)-苯磺酰胺(L1)作为螯合配体混合,制备了一系列新的金属配合物。酒精介质中的钒(V),镉(Cd)和银(Ag)离子。通过使用火焰原子吸收,C.H.N.S元素分析,FT-IR,UV-Vis光谱,电导率和磁化率测量,对配合物进行固态表征。对于CdL1L2,AgL1L2配合物,建议采用四面体几何形状,而VL1L2配合物则为方形锥体。具有金属离子的配体L1显然表现为通过磺酰胺的O和N原子的二齿,而对于所有配合物,L2表现为通过N和N原子的二齿。电导率表明所有制剂配合物均被电离,并且通过使用合适的Tanaba-Sugano图计算配体场参数来证明金属离子与配体供体原子之间的键合性质。分别研究了不同浓度(50、100、250、500和1000)ppm的V(IV),Cd(II),Ag(I),TMP和SMX的生物活性,具有螯合配体和co的配合物在37°C下孵育24小时后,对-配体针对金黄色葡萄球菌,假单胞菌,铜绿假单胞菌和大肠杆菌进行了评估。结果表明,浓度(50、100、250、500和1000)时,L1和L2增强(V)对金黄色葡萄球菌和大肠杆菌的生长的作用。 ppm,而 Ps。在37oC下孵育24小时后,将铜绿假单胞菌对(Cd)和(Ag)的浓度增至(250)ppm以上。鉴于SMX对抗Staph的效率很低。 金黄色葡萄球, Ps。 aeruginosa和 E。 大肠杆菌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号